Biotech enterprise Peijia Medical launched a Hong Kong initial public offering today to raise about HK$2.34 billion. The minimum investment is HK$15,514.78. The company is offering 152 million shares at an indicative price of HK$15.34. Also, Central China New Life begins its Hong Kong initial public offering today to raise HK$2.16 billion. The group is offering 300 million shares at an indicative price range of HK$5.6 to HK$7.2.

Source: The Standard May 05, 2020 08:24 UTC